C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2004
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/18/2004	CA2523743A1 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476441A1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
11/17/2004	EP1476440A2 Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
11/17/2004	EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476411A1 Method for producing 1,2-dichloroethane by direct chlorination
11/17/2004	EP1476164A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0888338B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) 1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
11/17/2004	EP0765477A4 Resins for solid state synthesis
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1546488A Diepoxy group containing thioxanthone photoinitiator and preparation method therefor
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/16/2004	US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818715 Ligand system for novel complexes containing late transition metals which can be used for polymerization of unsaturated compounds and give branched polymers
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818652 Heterocyclic retinoid compounds
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096773A1 Quinolone derivatives
11/11/2004	WO2004096768A1 Anti-diabetic agents
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096763A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
11/11/2004	WO2004096286A2 Antiviral phosphonate analogs
11/11/2004	WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004	WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004096128A2 Hiv integrase inhibitors
11/11/2004	WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003059258A3 Compositions and methods for treating heart failure
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040225000 4-(R'-Imino)-3-Mercapto-5-(R)4H-1,2,4-Triazols, 4-(R'-imino)-3-alkylthio-5-R-1,2,4-triazoles and 4-amino-3-mercapto-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224946 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2524251A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2523102A1 Substituted indoline and indole derivatives
11/11/2004	CA2523083A1 Antiviral phosphonate analogs
11/11/2004	CA2523020A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	CA2522262A1 Inhibitors of akt activity
11/11/2004	CA2521962A1 Anti-diabetic agents
11/11/2004	CA2519840A1 Anti-cancer phosphonate analogs
11/11/2004	CA2518753A1 Quinolone derivatives
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1474422A1 R− (−) −1− 2− &lpar ;7−CHLOROBENZO i b /i THIOPHEN−3 &minus ;YL− METHOXY) −2− (2,4−DICHLOROPHENYL) −ETHYL −1 i H /i −IMID AZOLE
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545507A Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/09/2004	US6815547 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094412A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	WO2004094411A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds

1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 523